Treatment of choroidal neovascularization in AMD.
Weinberg
David V
DV
Jampol
Lee M
LM
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D008268:Macular Degeneration / Q000150:complications / Q000188:drug therapy*; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D011244:Pregnadienediols / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D000077362:Verteporfin
D020533:Angiogenesis Inhibitors; D017319:Photosensitizing Agents; D011166:Porphyrins; D011244:Pregnadienediols; D000077362:Verteporfin; C418047:anecortave acetate